| |
Latest 10 SEC filings (by transaction date) for CELZ within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Jun 29/23 | Jun 28/23 | Warbington Timothy | Direct Ownership | Common Stock | P - Open market or private purchase | 200 | $4.36 |
Jun 29/23 | Jun 27/23 | Warbington Timothy | Direct Ownership | Common Stock | P - Open market or private purchase | 200 | $4.48 |
Jun 29/23 | Jun 27/23 | Warbington Timothy | Direct Ownership | Common Stock | P - Open market or private purchase | 300 | $4.45 |
Jun 29/23 | Jun 27/23 | Warbington Timothy | Direct Ownership | Common Stock | P - Open market or private purchase | 300 | $4.40 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for CELZ within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Jun 29/23 | Jun 28/23 | Warbington Timothy | Direct Ownership | Common Stock | P - Open market or private purchase | 200 | $4.36 |
Jun 29/23 | Jun 27/23 | Warbington Timothy | Direct Ownership | Common Stock | P - Open market or private purchase | 200 | $4.48 |
Jun 29/23 | Jun 27/23 | Warbington Timothy | Direct Ownership | Common Stock | P - Open market or private purchase | 300 | $4.45 |
Jun 29/23 | Jun 27/23 | Warbington Timothy | Direct Ownership | Common Stock | P - Open market or private purchase | 300 | $4.40 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |